路透社华盛顿6月3日 - 美国卫生与公众服务部部长小罗伯特-肯尼迪(Robert F. Kennedy Jr.)周二表示,Moderna公司已同意对其新型COVID-19疫苗进行真正的安慰剂对照试验。
肯尼迪指出,他知道人们对食品药品管理局有限批准高风险人群使用新型 mRNA 疫苗的担忧,但他保证该机构将在整个试验过程中对每一种不良结果进行监测并收集数据。
(为便利非英文母语者,路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误,或未能包含所需语境,路透不保证自动化翻译文本的准确性,仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失,路透不承担任何责任。)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.